Stocks and Investing Stocks and Investing
Tue, March 28, 2023
Mon, March 27, 2023
Fri, March 24, 2023
Thu, March 23, 2023

Geulah Livshits Maintained (SNTI) at Strong Buy with Decreased Target to $70 on, Mar 23rd, 2023


Published on 2024-10-28 02:23:33 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Senti Biosciences, Inc." (SNTI) at Strong Buy with Decreased Target from $80 to $70 on, Mar 23rd, 2023.

Geulah has made no other calls on SNTI in the last 4 months.



There are 2 other peers that have a rating on SNTI. Out of the 2 peers that are also analyzing SNTI, all agree with Geulah's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $30 on, Friday, January 27th, 2023
  • Brian Cheng of "JP Morgan" Initiated at Hold on, Friday, December 16th, 2022